Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
A recent Yahoo Finance item pointed to Goldman Sachs (GS) as one of the most watched stocks among Zacks.com users, framing the discussion around what investors should consider beyond the headline reason the shares are getting attention.
THE APEX TIMES
THE APEX TIMES
The automaker is using soccer culture to connect with Latino fans through a new brand campaign built around endurance, resilience, and community.
THE APEX TIMES
The telecom provider says its new, more advanced SecurityEdge tier is now available across the country, positioning it as an easier, bundled way for smaller businesses to manage cyber risk.
THE APEX TIMES
The soft-drink company is backing a multi-brand “Match Day” sweepstakes and fan experience centered on Major League Soccer and the U.S. men’s and women’s national team ecosystem, as soccer heats up in the summer months.
THE APEX TIMES
In a note discussed in market coverage, Goldman Sachs said consensus forecasts for 2027 capital expenditures by major cloud and AI infrastructure providers are “too conservative,” arguing that AI infrastructure buildouts will require materially more spending than many estimates assume.
THE APEX TIMES
The distributor is offering commemorative packaging tied to the U.S. 250th birthday, with limited availability announced on June 11.
THE APEX TIMES
A broad pullback hit software and semiconductor names, but gains in chips and memory suggested traders were moving selectively rather than exiting the whole sector.
THE APEX TIMES
A recent market recap argues that Amazon’s “buy-and-hold” potential depends on whether the company’s expanding logistics, retail scale, and cloud business can outpace rising spending and shifting demand. The company did not disclose new metrics in the cited post, leaving readers to judge the durability of its model largely through previously reported performance.
THE APEX TIMES
A new comparison piece pits fast-growing, still-unprofitable Lexicon Pharmaceuticals against Pfizer’s mature, globally diversified business and steadier cash generation, framing the trade-off investors weigh heading into 2026.
